EN
Competency
Our Commitment to Excellence
Product
Offering

70+ Years of Excellence

Experience in Marketing with Globally Recognized Quality

Building Pharma Excellence

1953

Since

 

Global Partners

35+

Countries

 

US FDA & Japan PMDA Inspections

20+

Years

Yung Shin Pharma (YSP) is committed to delivering superior value by providing high-quality, affordable healthcare products. Since 1952, YSP has developed, manufactured, and marketed solutions that improve lives and meet our clients' evolving needs. We drive our sustainable growth through in-house innovation, supporting a diversified product pipeline, strategic partnerships, and global collaboration within the Yung Shin Group.

With over two decades of successful US FDA and Japan PMDA inspections, we have built a reliable and comprehensive quality management system that ensures strict compliance with international GMP standards. Yung Shin provides specialized CMO/CDMO services, supported by a robust technological platform capable of handling a wide range of finished dosage forms (FDFs) as well as APIs.

Yung Shin supports partners in over 35 countries, such as USA, Japan, and Australia, by providing high-quality products and professional regulatory and product registration services, empowering them to thrive in complex global markets.

Integrated R&D and Manufacturing Solutions

Fermentation

 
  • Broad Microbial Platforms: Bacillus, Yeast, and Fungi
  • Strain Improvement
  • Structurally complex API produced via biotransformation
  • Scalable Fermentation Capacity: from 50L to 50,000L Fermenters

Chemical Synthetic

 
  • Extensive Organic Chemistry expertise:hydrogenation, bromination, solid-phase peptide synthesis, name reaction, column purification, micronization… etc.
  • Process Optimization
  • Flexible Production Scale: from lab scale to commercialization (up to hundreds of kgs)

Comprehensive Formulation Platforms

 

Microspheres, Liposomes

Intelligent Quality Management System

 

SAP, APS, EQMS, LIMS, Empower

Mature Formulations

 

Modified-Release (Repeated-Release, Matrix, Delayed-Release, Multiple-Unit Pellets), Solid Dispersion, Multiple-Layer tablet, Lyophilization, Orally-Disintegrating tablet

Specialized Production Lines

 

Dedicated, separate manufacturing facilities for Penicillin and Cephalosporin

MVersatile Dosage Forms

 

Injectables (liquid, powder-fill, lyophilized, including OEB4 products), Tablets, Capsules, Granules, Oral Suspensions, and Topicals

Our Commitment to Excellence

Ambition

Selling Health Beyond Borders

Integrated. Innovative. Trusted. Delivering world-class pharma solutions worldwide

Core Focus Area

From Lab to Life

Expert in small molecules, peptides, and HPAPIs —delivering excellence across diverse dosage forms.

Global GMP Approval

One World-Class Standard

Approved by 10+ global authorities (FDA, PMDA, TGA, Health Canada, PIC/S…), trusted worldwide.

Integrated Services

End-to-End CDMO, Speeding Your Success

Fully integrated, end-to-end solutions —from R&D to market, faster and smarter.

Global GMP Milestone

Building Trust Through International Standards

 
 
 
 

1980

Taiwan GMP

In-house QA/QC established.
The first Taiwan GMP certified facility.

 
 
 
 

1986

Taiwan GMP

All the facility is cGMP certified

 
 
 
 

2002

USA FDA

API Plant

 
 
 
 

2004

USA FDA

First oral DP plant ANDA approval

 
 
 
 

2007

Taiwan

Establish risk assessment protocol

 
 
 
 

2009

Japan PMDA

DP (Injectable)

 
 
 
 

2012

Taiwan GDP

GDP certified

 
 
 
 

2014

Japan PMDA

DP(Oncology injectable & General Injectable)

 
 
 
 

2018

USA FDA

USA FDA inspection

 
 
 
 

2019

USA FDA

DP (DR Tablets)

 
 
 
 

2022

Australia TGA

DP (Oral dosage form)

 
 
 
 

2023

Health Canada

DP (Oral dosage form)

 
 
 
 

2024

USA FDA

DP (Injectable-lyophilized)

Offering

Our Partnering Offerings

Licensing (Product/Technology)

Co-Development

Contract Services (CDMO/CMO)

 

Our Commitments to Partners

Licensing (Product/Technology)

Maximum flexibility at the highest quality level

Full support on all collaborative projects

Global Business Cooperation Division

+886-4-26815181 ext 510

GBCD@yungshingroup.com

 

Sales Regions & Contact Information

Europe / API / Enzymes

Kate Chang

u52348@yungshingroup.com

Artie Su

u52621@yungshingroup.com

United States / Canada / Australia

Amanda Chen

u51097@yungshingroup.com

Danny Lee

Danny.lee@yungshingroup.com

Africa / Mongolia / Hong Kong / ASEAN Countries / Middle East

Cupid Lee

u50310@yungshingroup.com

Hailey Hsu

u52629@yungshingroup.com

China / Taiwan / Japan

Stella Hsiao

u49727@yungshingroup.com

Yi-Chun Chang

u51061@yungshingroup.com